ENTITY

Zogenix Inc (ZGNX US)

2
Analysis
Health CareUnited States
Zogenix, Inc. is a specialty pharmaceutical company with proprietary product candidates in late-stage development for the treatment of central nervous system disorders and pain. The Company's products candidates include a product that enables needle-free subcutaneous delivery of sumatriptan for the treatment of acute migraine.
more
Publication Icon
No publications yet
There aren’t any broker reports right now
Back to "All"
x